Nonoxynol-9 Proposed Irritation/STD Infection Warning Revisions Requested
This article was originally published in The Tan Sheet
Executive Summary
FDA's proposed label warning for OTC nonoxynol-9- containing vaginal contraceptives cautioning that frequent use may increase the risk of infection with HIV or other sexually transmitted diseases "is not sufficiently supported by the scientific literature," Apothecus Pharmaceutical maintains in recent comments to the agency